GlobeNewswire
Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program
📊
AI Sentiment
Positive
7/10
- Home
- SER
as of 12-12-2025 9:40am EST
$3.25
+$0.11
+3.50%
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.
Chart Type:
Time Range:
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | HUNTSVILLE |
| Market Cap: | 42.0M | IPO Year: | 2018 |
| Target Price: | $13.00 | AVG Volume (30 days): | 14.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.92 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.14 - $7.92 | Next Earning Date: | 11-13-2025 |
| Revenue: | $116,000 | Revenue Growth: | -96.33% |
| Revenue Growth (this year): | 134.46% | Revenue Growth (next year): | N/A |
AI-Powered SER Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 72.88%
72.88%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Serina Therapeutics Inc. News
SER Breaking Stock News: Dive into SER Ticker-Specific Updates for Smart Investing
Compare SER vs Leading Stocks
See how SER stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SER Serina Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.